Alterity Therapeutics Ltd.ASX: ATH

US FDA Approval for IND Application for ATH434 for MSA

Sep 20, 2022 at 3:46 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd has released a press release.

View Attachment